HCID 131736341, compound → HCID 72704704, compound
Reaction equation
[CH2:1]([N:3]1[C:7]([CH:8]=[CH:9][C:10]2[C:19]([CH3:20])=[N:18][C:17]3[C:12](=[CH:13][CH:14]=[CH:15][CH:16]=3)[N:11]=2)=[N:6][C:5]([N:21]2[CH2:25][CH2:24][CH2:23][CH2:22]2)=[N:4]1)[CH3:2].[H][H]>C(OCC)(=O)C.[Pd]>[CH2:1]([N:3]1[C:7]([CH2:8][CH2:9][C:10]2[C:19]([CH3:20])=[N:18][C:17]3[C:12](=[CH:13][CH:14]=[CH:15][CH:16]=3)[N:11]=2)=[N:6][C:5]([N:21]2[CH2:22][CH2:23][CH2:24][CH2:25]2)=[N:4]1)[CH3:2]Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
2-(2-(1-ethyl-3-(pyrrolidin-1-yl)-1H-1,2,4-triazol-5-yl)vinyl)-3-methylquinoxaline (10 mg, 29.9 μmol, Eq: 1.00) was stirred in Ethyl acetate (6 ml) using 5% Pd on Ba2SO4 (3 mg, 30.8 μmol, Eq: 1.00) as catalyst in a hydrogen atmosphere. The mixture was stirred at room temperature for totally 12 h. TLC showed nearly complete conversion. The crude material was applied on silica gel an purified by column chromatography using ethyl acetate/methanol (0-5% methanol) as eluent to give 2-[2-(2-Ethyl-5-pyrrolidin-1-yl-2H-[1,2,4]triazol-3-yl)-ethyl]-3-methyl-quinoxaline (3.2 mg, 31.8%) as off-white semisolid
Workup
- customan purified by column chromatography
Sources & evidence
- ORD record
- ord-e40dd04c57f24bf9a178125eacf09c78
- Source dataset
- uspto-grants-2016_07
- Patent number
- US09394311B2
Reaction notes
Loading…